nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—CYP1A2—Dacarbazine—pancreatic cancer	0.0991	0.209	CbGbCtD
Imiquimod—CYP1A2—Tamoxifen—pancreatic cancer	0.0788	0.166	CbGbCtD
Imiquimod—CYP1A2—Erlotinib—pancreatic cancer	0.067	0.141	CbGbCtD
Imiquimod—CYP1A2—Fluorouracil—pancreatic cancer	0.0581	0.122	CbGbCtD
Imiquimod—CYP3A4—Tamoxifen—pancreatic cancer	0.0413	0.087	CbGbCtD
Imiquimod—CYP3A4—Erlotinib—pancreatic cancer	0.0351	0.0739	CbGbCtD
Imiquimod—CYP3A4—Irinotecan—pancreatic cancer	0.0317	0.0668	CbGbCtD
Imiquimod—CYP3A4—Docetaxel—pancreatic cancer	0.0232	0.0489	CbGbCtD
Imiquimod—CYP3A4—Sunitinib—pancreatic cancer	0.0231	0.0487	CbGbCtD
Imiquimod—CYP3A4—Doxorubicin—pancreatic cancer	0.0173	0.0365	CbGbCtD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—IFNA5—pancreatic cancer	0.00437	0.0466	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—IFNA5—pancreatic cancer	0.00341	0.0364	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—IFNA5—pancreatic cancer	0.00331	0.0353	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—IFNA5—pancreatic cancer	0.00259	0.0276	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—IFNA1—pancreatic cancer	0.0024	0.0256	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—IFNA2—pancreatic cancer	0.00223	0.0238	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—IFNA1—pancreatic cancer	0.00187	0.0199	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—IFNA1—pancreatic cancer	0.00182	0.0194	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—IFNA2—pancreatic cancer	0.00174	0.0186	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—IFNA2—pancreatic cancer	0.00169	0.018	CbGpPWpGaD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NFKBIA—pancreatic cancer	0.00167	0.0178	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—NFKBIA—pancreatic cancer	0.00164	0.0174	CbGpPWpGaD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—NFKBIA—pancreatic cancer	0.00158	0.0168	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—NFKBIA—pancreatic cancer	0.00145	0.0155	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—IFNA1—pancreatic cancer	0.00142	0.0151	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—PIK3CG—pancreatic cancer	0.00141	0.015	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—IFNA2—pancreatic cancer	0.00132	0.0141	CbGpPWpGaD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NFKBIA—pancreatic cancer	0.00126	0.0135	CbGpPWpGaD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—NFKBIA—pancreatic cancer	0.00124	0.0132	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—PIK3CD—pancreatic cancer	0.00124	0.0132	CbGpPWpGaD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—NFKBIA—pancreatic cancer	0.0012	0.0128	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—NFKBIA—pancreatic cancer	0.00113	0.0121	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—NFKBIA—pancreatic cancer	0.00112	0.012	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—NFKBIA—pancreatic cancer	0.0011	0.0117	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—PIK3CG—pancreatic cancer	0.0011	0.0117	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—IFNA5—pancreatic cancer	0.00109	0.0117	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—PIK3CB—pancreatic cancer	0.00108	0.0115	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—PIK3CG—pancreatic cancer	0.00107	0.0114	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—DTX4—pancreatic cancer	0.00106	0.0113	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—CXCL8—pancreatic cancer	0.00104	0.0111	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—PIK3CD—pancreatic cancer	0.000966	0.0103	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—PIK3CD—pancreatic cancer	0.000938	0.01	CbGpPWpGaD
Imiquimod—TLR8—Immune System—RAP1GAP—pancreatic cancer	0.000868	0.00925	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—NFKBIA—pancreatic cancer	0.00086	0.00917	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—NFKBIA—pancreatic cancer	0.00085	0.00907	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—PIK3CB—pancreatic cancer	0.000842	0.00898	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—PIK3CG—pancreatic cancer	0.000833	0.00888	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IFNA5—pancreatic cancer	0.000829	0.00884	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—PIK3CB—pancreatic cancer	0.000818	0.00872	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—CXCL8—pancreatic cancer	0.000809	0.00863	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—DTX4—pancreatic cancer	0.000804	0.00858	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—CXCL8—pancreatic cancer	0.000786	0.00838	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—PIK3CD—pancreatic cancer	0.000732	0.00781	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—TNF—pancreatic cancer	0.000722	0.0077	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—PIK3CA—pancreatic cancer	0.000658	0.00701	CbGpPWpGaD
Imiquimod—TLR7—Immune System—RAP1GAP—pancreatic cancer	0.000657	0.00701	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—PIK3CB—pancreatic cancer	0.000638	0.00681	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IFNA5—pancreatic cancer	0.000637	0.00679	CbGpPWpGaD
Imiquimod—TLR8—Immune System—DTX4—pancreatic cancer	0.000618	0.00659	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—CXCL8—pancreatic cancer	0.000613	0.00654	CbGpPWpGaD
Imiquimod—TLR8—Immune System—PPP2R5B—pancreatic cancer	0.000601	0.00641	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—IFNA1—pancreatic cancer	0.000599	0.00639	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—TNF—pancreatic cancer	0.000563	0.00601	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—IFNA2—pancreatic cancer	0.000558	0.00595	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—TNF—pancreatic cancer	0.000547	0.00583	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—AKT1—pancreatic cancer	0.000537	0.00573	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—PIK3CA—pancreatic cancer	0.000513	0.00548	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—AHR—pancreatic cancer	0.000507	0.00541	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—AHR—pancreatic cancer	0.000507	0.00541	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—PIK3CA—pancreatic cancer	0.000498	0.00532	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NFE2L2—pancreatic cancer	0.000494	0.00527	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—NFE2L2—pancreatic cancer	0.000494	0.00527	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IFNA5—pancreatic cancer	0.000483	0.00515	CbGpPWpGaD
Imiquimod—TLR7—Immune System—DTX4—pancreatic cancer	0.000468	0.005	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PPP2R5B—pancreatic cancer	0.000456	0.00486	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IFNA1—pancreatic cancer	0.000454	0.00484	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—TNF—pancreatic cancer	0.000427	0.00455	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IFNA2—pancreatic cancer	0.000423	0.00451	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—AKT1—pancreatic cancer	0.000419	0.00447	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—AKT1—pancreatic cancer	0.000407	0.00434	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—BCL2L1—pancreatic cancer	0.000401	0.00428	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—TSC2—pancreatic cancer	0.000399	0.00425	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—PIK3CA—pancreatic cancer	0.000389	0.00415	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—NFKBIA—pancreatic cancer	0.000363	0.00388	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CD44—pancreatic cancer	0.00036	0.00384	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IFNA1—pancreatic cancer	0.000349	0.00372	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—EGF—pancreatic cancer	0.000348	0.00371	CbGpPWpGaD
Imiquimod—CYP1A2—Estrogen Receptor Pathway—STAT3—pancreatic cancer	0.000331	0.00353	CbGpPWpGaD
Imiquimod—CYP1A2—Melatonin metabolism and effects—APOE—pancreatic cancer	0.000326	0.00347	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IFNA2—pancreatic cancer	0.000325	0.00346	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—AKT1—pancreatic cancer	0.000318	0.00339	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—PIK3CD—pancreatic cancer	0.000309	0.0033	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—BCL2L1—pancreatic cancer	0.000304	0.00324	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—TSC2—pancreatic cancer	0.000302	0.00322	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—NFKBIA—pancreatic cancer	0.000275	0.00294	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—pancreatic cancer	0.000275	0.00294	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CD44—pancreatic cancer	0.000273	0.00291	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—PIK3CB—pancreatic cancer	0.00027	0.00288	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IFNA1—pancreatic cancer	0.000264	0.00282	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—EGF—pancreatic cancer	0.000264	0.00281	CbGpPWpGaD
Imiquimod—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.00025	0.00266	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IFNA2—pancreatic cancer	0.000246	0.00262	CbGpPWpGaD
Imiquimod—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000243	0.000564	CcSEcCtD
Imiquimod—Breast disorder—Doxorubicin—pancreatic cancer	0.000241	0.000558	CcSEcCtD
Imiquimod—Abdominal pain—Irinotecan—pancreatic cancer	0.00024	0.000556	CcSEcCtD
Imiquimod—Body temperature increased—Irinotecan—pancreatic cancer	0.00024	0.000556	CcSEcCtD
Imiquimod—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000239	0.000555	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—CTNNB1—pancreatic cancer	0.000239	0.00255	CbGpPWpGaD
Imiquimod—Bronchitis—Epirubicin—pancreatic cancer	0.000239	0.000554	CcSEcCtD
Imiquimod—Pancytopenia—Epirubicin—pancreatic cancer	0.000236	0.000547	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—PIK3CD—pancreatic cancer	0.000235	0.0025	CbGpPWpGaD
Imiquimod—Vomiting—Sunitinib—pancreatic cancer	0.000234	0.000543	CcSEcCtD
Imiquimod—TLR8—Immune System—BCL2L1—pancreatic cancer	0.000234	0.00249	CbGpPWpGaD
Imiquimod—Body temperature increased—Gemcitabine—pancreatic cancer	0.000234	0.000541	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—PTEN—pancreatic cancer	0.000233	0.00249	CbGpPWpGaD
Imiquimod—Dysuria—Epirubicin—pancreatic cancer	0.000232	0.000539	CcSEcCtD
Imiquimod—TLR8—Immune System—TSC2—pancreatic cancer	0.000232	0.00248	CbGpPWpGaD
Imiquimod—Rash—Sunitinib—pancreatic cancer	0.000232	0.000538	CcSEcCtD
Imiquimod—Dermatitis—Sunitinib—pancreatic cancer	0.000232	0.000538	CcSEcCtD
Imiquimod—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000231	0.000536	CcSEcCtD
Imiquimod—Urticaria—Fluorouracil—pancreatic cancer	0.000231	0.000535	CcSEcCtD
Imiquimod—Headache—Sunitinib—pancreatic cancer	0.000231	0.000535	CcSEcCtD
Imiquimod—Syncope—Docetaxel—pancreatic cancer	0.00023	0.000534	CcSEcCtD
Imiquimod—Influenza—Doxorubicin—pancreatic cancer	0.00023	0.000533	CcSEcCtD
Imiquimod—Body temperature increased—Fluorouracil—pancreatic cancer	0.00023	0.000532	CcSEcCtD
Imiquimod—Palpitations—Docetaxel—pancreatic cancer	0.000227	0.000526	CcSEcCtD
Imiquimod—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000227	0.000526	CcSEcCtD
Imiquimod—Loss of consciousness—Docetaxel—pancreatic cancer	0.000226	0.000523	CcSEcCtD
Imiquimod—Cough—Docetaxel—pancreatic cancer	0.000224	0.00052	CcSEcCtD
Imiquimod—Hypersensitivity—Irinotecan—pancreatic cancer	0.000223	0.000518	CcSEcCtD
Imiquimod—Convulsion—Docetaxel—pancreatic cancer	0.000223	0.000516	CcSEcCtD
Imiquimod—Hypertension—Docetaxel—pancreatic cancer	0.000222	0.000514	CcSEcCtD
Imiquimod—Infestation—Epirubicin—pancreatic cancer	0.000222	0.000514	CcSEcCtD
Imiquimod—Infestation NOS—Epirubicin—pancreatic cancer	0.000222	0.000514	CcSEcCtD
Imiquimod—Bronchitis—Doxorubicin—pancreatic cancer	0.000221	0.000513	CcSEcCtD
Imiquimod—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.00022	0.000509	CcSEcCtD
Imiquimod—Myalgia—Docetaxel—pancreatic cancer	0.000219	0.000507	CcSEcCtD
Imiquimod—Chest pain—Docetaxel—pancreatic cancer	0.000219	0.000507	CcSEcCtD
Imiquimod—Arthralgia—Docetaxel—pancreatic cancer	0.000219	0.000507	CcSEcCtD
Imiquimod—Nausea—Sunitinib—pancreatic cancer	0.000219	0.000507	CcSEcCtD
Imiquimod—Pancytopenia—Doxorubicin—pancreatic cancer	0.000218	0.000506	CcSEcCtD
Imiquimod—Asthenia—Irinotecan—pancreatic cancer	0.000218	0.000504	CcSEcCtD
Imiquimod—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000217	0.000504	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000217	0.000503	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—SRC—pancreatic cancer	0.000216	0.00231	CbGpPWpGaD
Imiquimod—Conjunctivitis—Epirubicin—pancreatic cancer	0.000215	0.000499	CcSEcCtD
Imiquimod—Urinary tract infection—Epirubicin—pancreatic cancer	0.000215	0.000499	CcSEcCtD
Imiquimod—Dysuria—Doxorubicin—pancreatic cancer	0.000215	0.000499	CcSEcCtD
Imiquimod—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000214	0.000496	CcSEcCtD
Imiquimod—Dry mouth—Docetaxel—pancreatic cancer	0.000214	0.000496	CcSEcCtD
Imiquimod—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000214	0.000496	CcSEcCtD
Imiquimod—Asthenia—Gemcitabine—pancreatic cancer	0.000212	0.000491	CcSEcCtD
Imiquimod—TLR8—Immune System—NFKBIA—pancreatic cancer	0.000212	0.00226	CbGpPWpGaD
Imiquimod—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.00021	0.000487	CcSEcCtD
Imiquimod—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.00021	0.000486	CcSEcCtD
Imiquimod—Oedema—Docetaxel—pancreatic cancer	0.00021	0.000486	CcSEcCtD
Imiquimod—Pruritus—Gemcitabine—pancreatic cancer	0.000209	0.000484	CcSEcCtD
Imiquimod—Infection—Docetaxel—pancreatic cancer	0.000208	0.000483	CcSEcCtD
Imiquimod—Sinusitis—Epirubicin—pancreatic cancer	0.000208	0.000482	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—NRAS—pancreatic cancer	0.000208	0.00222	CbGpPWpGaD
Imiquimod—Diarrhoea—Irinotecan—pancreatic cancer	0.000207	0.000481	CcSEcCtD
Imiquimod—Shock—Docetaxel—pancreatic cancer	0.000206	0.000478	CcSEcCtD
Imiquimod—Nervous system disorder—Docetaxel—pancreatic cancer	0.000206	0.000477	CcSEcCtD
Imiquimod—Pruritus—Fluorouracil—pancreatic cancer	0.000205	0.000476	CcSEcCtD
Imiquimod—Infestation NOS—Doxorubicin—pancreatic cancer	0.000205	0.000475	CcSEcCtD
Imiquimod—Infestation—Doxorubicin—pancreatic cancer	0.000205	0.000475	CcSEcCtD
Imiquimod—Tachycardia—Docetaxel—pancreatic cancer	0.000205	0.000474	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—PIK3CB—pancreatic cancer	0.000204	0.00218	CbGpPWpGaD
Imiquimod—Skin disorder—Docetaxel—pancreatic cancer	0.000204	0.000472	CcSEcCtD
Imiquimod—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000203	0.000471	CcSEcCtD
Imiquimod—TLR8—Immune System—EGF—pancreatic cancer	0.000203	0.00216	CbGpPWpGaD
Imiquimod—Diarrhoea—Gemcitabine—pancreatic cancer	0.000202	0.000468	CcSEcCtD
Imiquimod—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000201	0.000466	CcSEcCtD
Imiquimod—Dizziness—Irinotecan—pancreatic cancer	0.000201	0.000465	CcSEcCtD
Imiquimod—Haemoglobin—Epirubicin—pancreatic cancer	0.0002	0.000464	CcSEcCtD
Imiquimod—Anorexia—Docetaxel—pancreatic cancer	0.0002	0.000463	CcSEcCtD
Imiquimod—Rhinitis—Epirubicin—pancreatic cancer	0.0002	0.000462	CcSEcCtD
Imiquimod—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000199	0.000462	CcSEcCtD
Imiquimod—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000199	0.000462	CcSEcCtD
Imiquimod—Haemorrhage—Epirubicin—pancreatic cancer	0.000199	0.000461	CcSEcCtD
Imiquimod—Diarrhoea—Fluorouracil—pancreatic cancer	0.000199	0.000461	CcSEcCtD
Imiquimod—Pharyngitis—Epirubicin—pancreatic cancer	0.000198	0.000458	CcSEcCtD
Imiquimod—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000197	0.000456	CcSEcCtD
Imiquimod—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000196	0.000453	CcSEcCtD
Imiquimod—Urethral disorder—Epirubicin—pancreatic cancer	0.000195	0.000452	CcSEcCtD
Imiquimod—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000194	0.00045	CcSEcCtD
Imiquimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000193	0.00206	CbGpPWpGaD
Imiquimod—Vomiting—Irinotecan—pancreatic cancer	0.000193	0.000447	CcSEcCtD
Imiquimod—Sinusitis—Doxorubicin—pancreatic cancer	0.000192	0.000446	CcSEcCtD
Imiquimod—Dizziness—Fluorouracil—pancreatic cancer	0.000192	0.000445	CcSEcCtD
Imiquimod—Visual impairment—Epirubicin—pancreatic cancer	0.000192	0.000445	CcSEcCtD
Imiquimod—Rash—Irinotecan—pancreatic cancer	0.000191	0.000443	CcSEcCtD
Imiquimod—Dermatitis—Irinotecan—pancreatic cancer	0.000191	0.000443	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000191	0.000443	CcSEcCtD
Imiquimod—Headache—Irinotecan—pancreatic cancer	0.00019	0.00044	CcSEcCtD
Imiquimod—Insomnia—Docetaxel—pancreatic cancer	0.00019	0.000439	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—EGFR—pancreatic cancer	0.000189	0.00202	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CDH1—pancreatic cancer	0.000189	0.00201	CbGpPWpGaD
Imiquimod—Paraesthesia—Docetaxel—pancreatic cancer	0.000188	0.000436	CcSEcCtD
Imiquimod—Erythema multiforme—Epirubicin—pancreatic cancer	0.000188	0.000436	CcSEcCtD
Imiquimod—Vomiting—Gemcitabine—pancreatic cancer	0.000188	0.000435	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—RB1—pancreatic cancer	0.000188	0.002	CbGpPWpGaD
Imiquimod—Dyspnoea—Docetaxel—pancreatic cancer	0.000187	0.000433	CcSEcCtD
Imiquimod—Somnolence—Docetaxel—pancreatic cancer	0.000186	0.000432	CcSEcCtD
Imiquimod—Rash—Gemcitabine—pancreatic cancer	0.000186	0.000432	CcSEcCtD
Imiquimod—Dermatitis—Gemcitabine—pancreatic cancer	0.000186	0.000431	CcSEcCtD
Imiquimod—Eye disorder—Epirubicin—pancreatic cancer	0.000186	0.000431	CcSEcCtD
Imiquimod—Tinnitus—Epirubicin—pancreatic cancer	0.000186	0.00043	CcSEcCtD
Imiquimod—Haemoglobin—Doxorubicin—pancreatic cancer	0.000185	0.000429	CcSEcCtD
Imiquimod—Headache—Gemcitabine—pancreatic cancer	0.000185	0.000429	CcSEcCtD
Imiquimod—Flushing—Epirubicin—pancreatic cancer	0.000185	0.000428	CcSEcCtD
Imiquimod—Vomiting—Fluorouracil—pancreatic cancer	0.000185	0.000428	CcSEcCtD
Imiquimod—Rhinitis—Doxorubicin—pancreatic cancer	0.000185	0.000428	CcSEcCtD
Imiquimod—Dyspepsia—Docetaxel—pancreatic cancer	0.000185	0.000428	CcSEcCtD
Imiquimod—Haemorrhage—Doxorubicin—pancreatic cancer	0.000184	0.000427	CcSEcCtD
Imiquimod—Rash—Fluorouracil—pancreatic cancer	0.000183	0.000424	CcSEcCtD
Imiquimod—Dermatitis—Fluorouracil—pancreatic cancer	0.000183	0.000424	CcSEcCtD
Imiquimod—Pharyngitis—Doxorubicin—pancreatic cancer	0.000183	0.000424	CcSEcCtD
Imiquimod—Decreased appetite—Docetaxel—pancreatic cancer	0.000182	0.000422	CcSEcCtD
Imiquimod—Headache—Fluorouracil—pancreatic cancer	0.000182	0.000422	CcSEcCtD
Imiquimod—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000182	0.000422	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—CTNNB1—pancreatic cancer	0.000181	0.00193	CbGpPWpGaD
Imiquimod—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000181	0.000419	CcSEcCtD
Imiquimod—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000181	0.000419	CcSEcCtD
Imiquimod—Fatigue—Docetaxel—pancreatic cancer	0.000181	0.000419	CcSEcCtD
Imiquimod—Angiopathy—Epirubicin—pancreatic cancer	0.000181	0.000419	CcSEcCtD
Imiquimod—Urethral disorder—Doxorubicin—pancreatic cancer	0.000181	0.000418	CcSEcCtD
Imiquimod—TLR8—Immune System—PIK3CD—pancreatic cancer	0.00018	0.00192	CbGpPWpGaD
Imiquimod—Nausea—Irinotecan—pancreatic cancer	0.00018	0.000418	CcSEcCtD
Imiquimod—Immune system disorder—Epirubicin—pancreatic cancer	0.00018	0.000417	CcSEcCtD
Imiquimod—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000179	0.000416	CcSEcCtD
Imiquimod—Pain—Docetaxel—pancreatic cancer	0.000179	0.000416	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—KRAS—pancreatic cancer	0.000179	0.00191	CbGpPWpGaD
Imiquimod—Chills—Epirubicin—pancreatic cancer	0.000179	0.000414	CcSEcCtD
Imiquimod—Arrhythmia—Epirubicin—pancreatic cancer	0.000178	0.000412	CcSEcCtD
Imiquimod—Visual impairment—Doxorubicin—pancreatic cancer	0.000177	0.000411	CcSEcCtD
Imiquimod—TLR7—Immune System—BCL2L1—pancreatic cancer	0.000177	0.00189	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—PTEN—pancreatic cancer	0.000177	0.00188	CbGpPWpGaD
Imiquimod—TLR7—Immune System—TSC2—pancreatic cancer	0.000176	0.00188	CbGpPWpGaD
Imiquimod—Alopecia—Epirubicin—pancreatic cancer	0.000176	0.000408	CcSEcCtD
Imiquimod—Nausea—Gemcitabine—pancreatic cancer	0.000175	0.000407	CcSEcCtD
Imiquimod—Mental disorder—Epirubicin—pancreatic cancer	0.000174	0.000404	CcSEcCtD
Imiquimod—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000174	0.000404	CcSEcCtD
Imiquimod—Malnutrition—Epirubicin—pancreatic cancer	0.000173	0.000402	CcSEcCtD
Imiquimod—Erythema—Epirubicin—pancreatic cancer	0.000173	0.000402	CcSEcCtD
Imiquimod—Feeling abnormal—Docetaxel—pancreatic cancer	0.000173	0.0004	CcSEcCtD
Imiquimod—Nausea—Fluorouracil—pancreatic cancer	0.000173	0.0004	CcSEcCtD
Imiquimod—Eye disorder—Doxorubicin—pancreatic cancer	0.000172	0.000399	CcSEcCtD
Imiquimod—Tinnitus—Doxorubicin—pancreatic cancer	0.000172	0.000398	CcSEcCtD
Imiquimod—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000171	0.000397	CcSEcCtD
Imiquimod—Flushing—Doxorubicin—pancreatic cancer	0.000171	0.000396	CcSEcCtD
Imiquimod—Back pain—Epirubicin—pancreatic cancer	0.000168	0.000388	CcSEcCtD
Imiquimod—Angiopathy—Doxorubicin—pancreatic cancer	0.000167	0.000387	CcSEcCtD
Imiquimod—Immune system disorder—Doxorubicin—pancreatic cancer	0.000166	0.000386	CcSEcCtD
Imiquimod—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000166	0.000385	CcSEcCtD
Imiquimod—Abdominal pain—Docetaxel—pancreatic cancer	0.000166	0.000384	CcSEcCtD
Imiquimod—Body temperature increased—Docetaxel—pancreatic cancer	0.000166	0.000384	CcSEcCtD
Imiquimod—Chills—Doxorubicin—pancreatic cancer	0.000165	0.000383	CcSEcCtD
Imiquimod—Arrhythmia—Doxorubicin—pancreatic cancer	0.000164	0.000381	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—PIK3CA—pancreatic cancer	0.000164	0.00175	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—SRC—pancreatic cancer	0.000164	0.00175	CbGpPWpGaD
Imiquimod—Alopecia—Doxorubicin—pancreatic cancer	0.000163	0.000377	CcSEcCtD
Imiquimod—Mental disorder—Doxorubicin—pancreatic cancer	0.000161	0.000374	CcSEcCtD
Imiquimod—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000161	0.000373	CcSEcCtD
Imiquimod—TLR7—Immune System—NFKBIA—pancreatic cancer	0.00016	0.00171	CbGpPWpGaD
Imiquimod—Erythema—Doxorubicin—pancreatic cancer	0.00016	0.000372	CcSEcCtD
Imiquimod—Malnutrition—Doxorubicin—pancreatic cancer	0.00016	0.000372	CcSEcCtD
Imiquimod—Agitation—Epirubicin—pancreatic cancer	0.000159	0.000369	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—NRAS—pancreatic cancer	0.000158	0.00168	CbGpPWpGaD
Imiquimod—TLR8—Immune System—PIK3CB—pancreatic cancer	0.000157	0.00168	CbGpPWpGaD
Imiquimod—Malaise—Epirubicin—pancreatic cancer	0.000156	0.000362	CcSEcCtD
Imiquimod—Syncope—Epirubicin—pancreatic cancer	0.000155	0.00036	CcSEcCtD
Imiquimod—Back pain—Doxorubicin—pancreatic cancer	0.000155	0.000359	CcSEcCtD
Imiquimod—Hypersensitivity—Docetaxel—pancreatic cancer	0.000154	0.000358	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—pancreatic cancer	0.000154	0.00165	CbGpPWpGaD
Imiquimod—TLR7—Immune System—EGF—pancreatic cancer	0.000154	0.00164	CbGpPWpGaD
Imiquimod—Palpitations—Epirubicin—pancreatic cancer	0.000153	0.000355	CcSEcCtD
Imiquimod—Loss of consciousness—Epirubicin—pancreatic cancer	0.000152	0.000353	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—HRAS—pancreatic cancer	0.000152	0.00162	CbGpPWpGaD
Imiquimod—Cough—Epirubicin—pancreatic cancer	0.000151	0.00035	CcSEcCtD
Imiquimod—Asthenia—Docetaxel—pancreatic cancer	0.00015	0.000349	CcSEcCtD
Imiquimod—Convulsion—Epirubicin—pancreatic cancer	0.00015	0.000348	CcSEcCtD
Imiquimod—Hypertension—Epirubicin—pancreatic cancer	0.00015	0.000347	CcSEcCtD
Imiquimod—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000149	0.000345	CcSEcCtD
Imiquimod—Pruritus—Docetaxel—pancreatic cancer	0.000148	0.000344	CcSEcCtD
Imiquimod—Chest pain—Epirubicin—pancreatic cancer	0.000147	0.000342	CcSEcCtD
Imiquimod—Myalgia—Epirubicin—pancreatic cancer	0.000147	0.000342	CcSEcCtD
Imiquimod—Arthralgia—Epirubicin—pancreatic cancer	0.000147	0.000342	CcSEcCtD
Imiquimod—Agitation—Doxorubicin—pancreatic cancer	0.000147	0.000341	CcSEcCtD
Imiquimod—Anxiety—Epirubicin—pancreatic cancer	0.000147	0.000341	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000146	0.00034	CcSEcCtD
Imiquimod—Discomfort—Epirubicin—pancreatic cancer	0.000146	0.000338	CcSEcCtD
Imiquimod—Malaise—Doxorubicin—pancreatic cancer	0.000145	0.000335	CcSEcCtD
Imiquimod—CYP1A2—Arachidonic acid metabolism—PTGS2—pancreatic cancer	0.000144	0.00154	CbGpPWpGaD
Imiquimod—Dry mouth—Epirubicin—pancreatic cancer	0.000144	0.000334	CcSEcCtD
Imiquimod—Syncope—Doxorubicin—pancreatic cancer	0.000144	0.000333	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—EGFR—pancreatic cancer	0.000144	0.00153	CbGpPWpGaD
Imiquimod—Diarrhoea—Docetaxel—pancreatic cancer	0.000143	0.000332	CcSEcCtD
Imiquimod—TLR7—Immune System—CDH1—pancreatic cancer	0.000143	0.00152	CbGpPWpGaD
Imiquimod—Palpitations—Doxorubicin—pancreatic cancer	0.000142	0.000328	CcSEcCtD
Imiquimod—Oedema—Epirubicin—pancreatic cancer	0.000141	0.000328	CcSEcCtD
Imiquimod—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000141	0.000327	CcSEcCtD
Imiquimod—Infection—Epirubicin—pancreatic cancer	0.00014	0.000326	CcSEcCtD
Imiquimod—Cough—Doxorubicin—pancreatic cancer	0.00014	0.000324	CcSEcCtD
Imiquimod—TLR8—Immune System—CTNNB1—pancreatic cancer	0.000139	0.00149	CbGpPWpGaD
Imiquimod—Shock—Epirubicin—pancreatic cancer	0.000139	0.000322	CcSEcCtD
Imiquimod—Convulsion—Doxorubicin—pancreatic cancer	0.000139	0.000322	CcSEcCtD
Imiquimod—Nervous system disorder—Epirubicin—pancreatic cancer	0.000139	0.000321	CcSEcCtD
Imiquimod—Dizziness—Docetaxel—pancreatic cancer	0.000139	0.000321	CcSEcCtD
Imiquimod—Hypertension—Doxorubicin—pancreatic cancer	0.000138	0.000321	CcSEcCtD
Imiquimod—Tachycardia—Epirubicin—pancreatic cancer	0.000138	0.00032	CcSEcCtD
Imiquimod—Skin disorder—Epirubicin—pancreatic cancer	0.000137	0.000318	CcSEcCtD
Imiquimod—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000137	0.000317	CcSEcCtD
Imiquimod—TLR7—Immune System—PIK3CD—pancreatic cancer	0.000137	0.00146	CbGpPWpGaD
Imiquimod—Arthralgia—Doxorubicin—pancreatic cancer	0.000136	0.000316	CcSEcCtD
Imiquimod—Myalgia—Doxorubicin—pancreatic cancer	0.000136	0.000316	CcSEcCtD
Imiquimod—Chest pain—Doxorubicin—pancreatic cancer	0.000136	0.000316	CcSEcCtD
Imiquimod—Anxiety—Doxorubicin—pancreatic cancer	0.000136	0.000315	CcSEcCtD
Imiquimod—TLR8—Immune System—PTEN—pancreatic cancer	0.000136	0.00145	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—KRAS—pancreatic cancer	0.000136	0.00145	CbGpPWpGaD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000136	0.000314	CcSEcCtD
Imiquimod—Discomfort—Doxorubicin—pancreatic cancer	0.000135	0.000313	CcSEcCtD
Imiquimod—Anorexia—Epirubicin—pancreatic cancer	0.000135	0.000312	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—AKT1—pancreatic cancer	0.000134	0.00143	CbGpPWpGaD
Imiquimod—Dry mouth—Doxorubicin—pancreatic cancer	0.000133	0.000309	CcSEcCtD
Imiquimod—Vomiting—Docetaxel—pancreatic cancer	0.000133	0.000309	CcSEcCtD
Imiquimod—Rash—Docetaxel—pancreatic cancer	0.000132	0.000306	CcSEcCtD
Imiquimod—Dermatitis—Docetaxel—pancreatic cancer	0.000132	0.000306	CcSEcCtD
Imiquimod—Headache—Docetaxel—pancreatic cancer	0.000131	0.000304	CcSEcCtD
Imiquimod—Oedema—Doxorubicin—pancreatic cancer	0.000131	0.000303	CcSEcCtD
Imiquimod—Infection—Doxorubicin—pancreatic cancer	0.00013	0.000301	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000129	0.000299	CcSEcCtD
Imiquimod—Shock—Doxorubicin—pancreatic cancer	0.000129	0.000298	CcSEcCtD
Imiquimod—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000128	0.000297	CcSEcCtD
Imiquimod—Insomnia—Epirubicin—pancreatic cancer	0.000128	0.000296	CcSEcCtD
Imiquimod—Tachycardia—Doxorubicin—pancreatic cancer	0.000128	0.000296	CcSEcCtD
Imiquimod—Skin disorder—Doxorubicin—pancreatic cancer	0.000127	0.000295	CcSEcCtD
Imiquimod—Paraesthesia—Epirubicin—pancreatic cancer	0.000127	0.000294	CcSEcCtD
Imiquimod—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000126	0.000293	CcSEcCtD
Imiquimod—Dyspnoea—Epirubicin—pancreatic cancer	0.000126	0.000292	CcSEcCtD
Imiquimod—TLR8—Immune System—SRC—pancreatic cancer	0.000126	0.00134	CbGpPWpGaD
Imiquimod—Somnolence—Epirubicin—pancreatic cancer	0.000126	0.000291	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—pancreatic cancer	0.000125	0.00133	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—SRC—pancreatic cancer	0.000125	0.00133	CbGpPWpGaD
Imiquimod—Anorexia—Doxorubicin—pancreatic cancer	0.000125	0.000289	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—PIK3CA—pancreatic cancer	0.000125	0.00133	CbGpPWpGaD
Imiquimod—Nausea—Docetaxel—pancreatic cancer	0.000125	0.000289	CcSEcCtD
Imiquimod—Dyspepsia—Epirubicin—pancreatic cancer	0.000124	0.000288	CcSEcCtD
Imiquimod—Decreased appetite—Epirubicin—pancreatic cancer	0.000123	0.000285	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000122	0.000283	CcSEcCtD
Imiquimod—Fatigue—Epirubicin—pancreatic cancer	0.000122	0.000283	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—pancreatic cancer	0.000122	0.0013	CbGpPWpGaD
Imiquimod—TLR8—Immune System—STAT3—pancreatic cancer	0.000121	0.00129	CbGpPWpGaD
Imiquimod—TLR8—Immune System—NRAS—pancreatic cancer	0.000121	0.00129	CbGpPWpGaD
Imiquimod—Pain—Epirubicin—pancreatic cancer	0.000121	0.00028	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—pancreatic cancer	0.00012	0.00128	CbGpPWpGaD
Imiquimod—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000119	0.000276	CcSEcCtD
Imiquimod—TLR7—Immune System—PIK3CB—pancreatic cancer	0.000119	0.00127	CbGpPWpGaD
Imiquimod—Insomnia—Doxorubicin—pancreatic cancer	0.000118	0.000274	CcSEcCtD
Imiquimod—Paraesthesia—Doxorubicin—pancreatic cancer	0.000117	0.000272	CcSEcCtD
Imiquimod—Dyspnoea—Doxorubicin—pancreatic cancer	0.000117	0.00027	CcSEcCtD
Imiquimod—Feeling abnormal—Epirubicin—pancreatic cancer	0.000117	0.00027	CcSEcCtD
Imiquimod—Somnolence—Doxorubicin—pancreatic cancer	0.000116	0.00027	CcSEcCtD
Imiquimod—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000116	0.000268	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—HRAS—pancreatic cancer	0.000115	0.00123	CbGpPWpGaD
Imiquimod—Dyspepsia—Doxorubicin—pancreatic cancer	0.000115	0.000267	CcSEcCtD
Imiquimod—Decreased appetite—Doxorubicin—pancreatic cancer	0.000114	0.000264	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000113	0.000262	CcSEcCtD
Imiquimod—Fatigue—Doxorubicin—pancreatic cancer	0.000113	0.000261	CcSEcCtD
Imiquimod—Urticaria—Epirubicin—pancreatic cancer	0.000112	0.00026	CcSEcCtD
Imiquimod—Pain—Doxorubicin—pancreatic cancer	0.000112	0.000259	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—MYC—pancreatic cancer	0.000112	0.00119	CbGpPWpGaD
Imiquimod—Abdominal pain—Epirubicin—pancreatic cancer	0.000112	0.000259	CcSEcCtD
Imiquimod—Body temperature increased—Epirubicin—pancreatic cancer	0.000112	0.000259	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—pancreatic cancer	0.000112	0.00119	CbGpPWpGaD
Imiquimod—TLR8—Immune System—EGFR—pancreatic cancer	0.00011	0.00118	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pancreatic cancer	0.000109	0.00117	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pancreatic cancer	0.000109	0.00117	CbGpPWpGaD
Imiquimod—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000108	0.00025	CcSEcCtD
Imiquimod—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000107	0.000248	CcSEcCtD
Imiquimod—TLR7—Immune System—CTNNB1—pancreatic cancer	0.000106	0.00113	CbGpPWpGaD
Imiquimod—TLR8—Immune System—KRAS—pancreatic cancer	0.000104	0.00111	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—pancreatic cancer	0.000104	0.00111	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—TNF—pancreatic cancer	0.000104	0.00111	CbGpPWpGaD
Imiquimod—Hypersensitivity—Epirubicin—pancreatic cancer	0.000104	0.000241	CcSEcCtD
Imiquimod—Urticaria—Doxorubicin—pancreatic cancer	0.000104	0.000241	CcSEcCtD
Imiquimod—Abdominal pain—Doxorubicin—pancreatic cancer	0.000103	0.00024	CcSEcCtD
Imiquimod—Body temperature increased—Doxorubicin—pancreatic cancer	0.000103	0.00024	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—pancreatic cancer	0.000103	0.0011	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PTEN—pancreatic cancer	0.000103	0.0011	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—AKT1—pancreatic cancer	0.000102	0.00109	CbGpPWpGaD
Imiquimod—Asthenia—Epirubicin—pancreatic cancer	0.000101	0.000235	CcSEcCtD
Imiquimod—Pruritus—Epirubicin—pancreatic cancer	0.0001	0.000232	CcSEcCtD
Imiquimod—Diarrhoea—Epirubicin—pancreatic cancer	9.67e-05	0.000224	CcSEcCtD
Imiquimod—Hypersensitivity—Doxorubicin—pancreatic cancer	9.64e-05	0.000223	CcSEcCtD
Imiquimod—TLR8—Immune System—PIK3CA—pancreatic cancer	9.58e-05	0.00102	CbGpPWpGaD
Imiquimod—TLR7—Immune System—SRC—pancreatic cancer	9.54e-05	0.00102	CbGpPWpGaD
Imiquimod—Asthenia—Doxorubicin—pancreatic cancer	9.39e-05	0.000218	CcSEcCtD
Imiquimod—Dizziness—Epirubicin—pancreatic cancer	9.35e-05	0.000217	CcSEcCtD
Imiquimod—Pruritus—Doxorubicin—pancreatic cancer	9.26e-05	0.000215	CcSEcCtD
Imiquimod—TLR7—Immune System—STAT3—pancreatic cancer	9.2e-05	0.000981	CbGpPWpGaD
Imiquimod—TLR7—Immune System—NRAS—pancreatic cancer	9.18e-05	0.000979	CbGpPWpGaD
Imiquimod—Vomiting—Epirubicin—pancreatic cancer	8.99e-05	0.000208	CcSEcCtD
Imiquimod—Diarrhoea—Doxorubicin—pancreatic cancer	8.95e-05	0.000207	CcSEcCtD
Imiquimod—Rash—Epirubicin—pancreatic cancer	8.91e-05	0.000207	CcSEcCtD
Imiquimod—Dermatitis—Epirubicin—pancreatic cancer	8.91e-05	0.000206	CcSEcCtD
Imiquimod—TLR8—Immune System—HRAS—pancreatic cancer	8.86e-05	0.000945	CbGpPWpGaD
Imiquimod—Headache—Epirubicin—pancreatic cancer	8.86e-05	0.000205	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	8.78e-05	0.000937	CbGpPWpGaD
Imiquimod—Dizziness—Doxorubicin—pancreatic cancer	8.65e-05	0.000201	CcSEcCtD
Imiquimod—Nausea—Epirubicin—pancreatic cancer	8.4e-05	0.000195	CcSEcCtD
Imiquimod—TLR7—Immune System—EGFR—pancreatic cancer	8.36e-05	0.000892	CbGpPWpGaD
Imiquimod—Vomiting—Doxorubicin—pancreatic cancer	8.32e-05	0.000193	CcSEcCtD
Imiquimod—Rash—Doxorubicin—pancreatic cancer	8.25e-05	0.000191	CcSEcCtD
Imiquimod—Dermatitis—Doxorubicin—pancreatic cancer	8.24e-05	0.000191	CcSEcCtD
Imiquimod—Headache—Doxorubicin—pancreatic cancer	8.2e-05	0.00019	CcSEcCtD
Imiquimod—TLR7—Immune System—KRAS—pancreatic cancer	7.9e-05	0.000842	CbGpPWpGaD
Imiquimod—TLR8—Immune System—AKT1—pancreatic cancer	7.82e-05	0.000834	CbGpPWpGaD
Imiquimod—Nausea—Doxorubicin—pancreatic cancer	7.77e-05	0.00018	CcSEcCtD
Imiquimod—TLR7—Immune System—PIK3CA—pancreatic cancer	7.26e-05	0.000774	CbGpPWpGaD
Imiquimod—TLR7—Immune System—HRAS—pancreatic cancer	6.71e-05	0.000716	CbGpPWpGaD
Imiquimod—TLR7—Immune System—AKT1—pancreatic cancer	5.93e-05	0.000632	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PRSS1—pancreatic cancer	4.81e-05	0.000513	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ARG2—pancreatic cancer	4.17e-05	0.000445	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PRSS1—pancreatic cancer	3.72e-05	0.000396	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—TYMP—pancreatic cancer	3.65e-05	0.000389	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ARG2—pancreatic cancer	3.22e-05	0.000344	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	3.01e-05	0.000321	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GLP1R—pancreatic cancer	2.94e-05	0.000314	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—DPYD—pancreatic cancer	2.89e-05	0.000309	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—TYMP—pancreatic cancer	2.82e-05	0.0003	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	2.75e-05	0.000293	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.72e-05	0.00029	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.62e-05	0.00028	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.39e-05	0.000255	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GLP1R—pancreatic cancer	2.27e-05	0.000242	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—DPYD—pancreatic cancer	2.23e-05	0.000238	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CD44—pancreatic cancer	2.13e-05	0.000227	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	2.12e-05	0.000226	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.08e-05	0.000222	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.06e-05	0.00022	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GCG—pancreatic cancer	2.04e-05	0.000217	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—STK11—pancreatic cancer	1.92e-05	0.000204	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.8e-05	0.000192	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—TYMS—pancreatic cancer	1.65e-05	0.000176	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CD44—pancreatic cancer	1.64e-05	0.000175	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GCG—pancreatic cancer	1.57e-05	0.000168	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—STK11—pancreatic cancer	1.48e-05	0.000158	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—APOE—pancreatic cancer	1.34e-05	0.000143	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—TYMS—pancreatic cancer	1.27e-05	0.000136	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.27e-05	0.000135	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	1.21e-05	0.000129	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PPARG—pancreatic cancer	1.17e-05	0.000125	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	1.06e-05	0.000113	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—APOE—pancreatic cancer	1.03e-05	0.00011	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	9.34e-06	9.96e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	9.27e-06	9.89e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PTGS2—pancreatic cancer	9.19e-06	9.8e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PPARG—pancreatic cancer	9.01e-06	9.61e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	8.21e-06	8.76e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PTEN—pancreatic cancer	8.01e-06	8.55e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	7.16e-06	7.63e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PTGS2—pancreatic cancer	7.09e-06	7.56e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PTEN—pancreatic cancer	6.18e-06	6.6e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	5.65e-06	6.03e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—AKT1—pancreatic cancer	4.62e-06	4.92e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	4.36e-06	4.65e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—AKT1—pancreatic cancer	3.56e-06	3.8e-05	CbGpPWpGaD
